NCT05705583View on ClinicalTrials.gov

A Companion Diagnostic Study to Develop Circulating Exosomes as Predictive Biomarkers for the Response to Immunotherapy in Renal Cell Carcinoma

RecruitingOBSERVATIONAL

Enrollment

100

Participants

Timeline

Start Date

January 1, 2023

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions

Renal Cell Carcinoma

Interventions

OTHER

Other: Blood and Urine Collection

Blood and Urine Collection

Trial Locations (1)

310022

RECRUITING

An Zhao, Hangzhou

All Listed Sponsors

lead

Zhejiang Cancer Hospital

OTHER